Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next
Author: PalmerB Big gold star, 5000 posts Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 242  
Subject: Quidel comments on earnings Date: 2/7/2000 4:09 PM
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Recommendations: 0

Quidel Comments on Earnings Outlook and Milestone Payment From Sumitomo

SAN DIEGO, Feb. 1 /PRNewswire/ -- Quidel Corporation (Nasdaq: QDEL) announced today that earnings for the quarter ended December 31, 1999, are expected to be between $.01 to $.03 per share. Quarterly results were impacted by the investments made to initiate the market launch of its QuickVue(R) Influenza Test, to acquire the Dade Behring urinalysis business, as well as to add staffing associated with the ramp up of production to a 24 hour, 7 days per week shift operation to meet increased demand. In addition, a non-recurring one-time mortgage prepayment penalty associated with the sale and leaseback of the corporate headquarters will be recorded in the quarter.

"Due to the fact that we are in the midst of our new fiscal year-end audit, when in the past, earnings would have already been announced, we are communicating these significant events impacting our business ahead of the release of audited earnings," said Andre de Bruin, Chief Executive Officer and President of Quidel.

"We are experiencing a substantial increase in our customer order rate in our core business," de Bruin continued. "During the month of December, we decided to make fairly significant unbudgeted investments in an effort to accommodate this increase and to accelerate the growth of some of our new businesses in the new fiscal year 2000."

The company also announced that it would show a $1 million one-time milestone payment from Sumitomo Pharmaceuticals Co. Ltd. in the quarter's results.

"The milestone payment from Sumitomo is significant in that if reflects reimbursement approval for our Metra bone markers in Japan," said de Bruin.

Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next

Announcements

Post of the Day:
Value Hounds

Medallion Financial: TAXI!
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement